Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
June 23, 2025Emma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis18 minutesPlayEmma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis...moreShareView all episodesBy PeerVoice3.266 ratingsJune 23, 2025Emma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis18 minutesPlayEmma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis...moreMore shows like PeerVoice Endocrinology & Metabolic Disorders AudioView allPeerVoice Brain Behaviour Audio0 ListenersPeerVoice Oncology & Haematology Audio1 ListenersPeerVoice Endocrinology & Metabolic Disorders Video2 ListenersPeerVoice Digestive Diseases Audio0 ListenersPeerVoice Digestive Diseases Video0 ListenersPeerVoice Immunology & Infectious Disease Video0 ListenersPeerVoice Immunology & Infectious Disease Audio1 ListenersDiabetes Core Update108 ListenersPeerVoice Internal Medicine Audio4 ListenersPeerVoice Internal Medicine Video0 ListenersJAMA Clinical Reviews493 ListenersThe Curbsiders Internal Medicine Podcast3,332 ListenersFiction - Comedy Fiction6,447 Listeners
Emma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis
June 23, 2025Emma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis18 minutesPlayEmma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis...more
Emma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis